Bright Minds Biosciences Inc. (DRUG)

NASDAQ

$74.54

-$0.46 (0.61%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$73.00$75.25

Open $74.20

52 Week Range

$23.18$123.75

Previous Close $75.00

Market Cap578.54M

Volume234.75K

Avg Volume168.45K

P/E (TTM)-40.57

EPS (TTM)$-2.56

Dividend / YieldN/A

Dividend StreakN/A

About Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Company Info

SectorHealthcare

IndustryBiotechnology

CEOIan McDonald

Employees26

Websitebrightmindsbio.com

Trading Information

Open

$74.20

Previous Close

$75.00

Day High

$75.25

Day Low

$73.00

52 Week High

$123.75

52 Week Low

$23.18